We ARE MOVING. New address effective July 6: #100 – 119 14 St. NW, Calgary, AB T2N 1Z6, Canada.
Search

CLIA-Certified Cytokine Testing for Physicians and Referring Labs

Jun
CLIA-Certified Cytokine Testing for Physicians and Referring Labs

CLIA-Certified Cytokine Testing for Physicians and Referring Labs

Looking for clinical cytokine testing options? Eve Technologies provides clinical diagnostic testing through Eve Diagnostics, our CLIA-certified clinical laboratory division. Eve Diagnostics is CLIA-certified for high-complexity testing in General Immunology (CLIA# 99D2283230), holds CDPH certification, and offers Laboratory Developed Tests (LDTs) in General Immunology. Our...

Read More
May
Cytokine Testing for Clinical Trials: Multiplex Biomarker Support for Early Phase Studies

Cytokine Testing for Clinical Trials: Multiplex Biomarker Support for Early Phase Studies

Early phase clinical trials often need more than standard safety data. In Phase 0, Phase I and Phase II studies, sponsors, CROs and research teams may also need to understand how a treatment affects immune activity, inflammation or disease related biological pathways. Cytokine testing for...

Read More
Apr
Lab technician wearing blue gloves handling sample tubes in a laboratory

Outsourcing Cytokine Testing vs In-House: Cost, Time, and Data Quality Compared

If your team is deciding whether to run cytokine assays internally or send samples to a specialized lab, treat it as an operations decision, not just a methods decision. The right choice depends on analyte count, sample volume, timeline, staff capacity, matrix complexity, and whether...

Read More
Mar
Promotional graphic for custom plex panel highlighting over 900 cytokine targets available for flexible, tailored multiplex biomarker analysis projects

Custom Multiplex Cytokine Panels: What Researchers Should Consider

Multiplex cytokine profiling has become a standard tool in immunology, oncology, neurology, and cardiovascular research. As studies become more targeted, many investigators consider custom multiplex cytokine panels to measure specific biomarkers relevant to their hypotheses. However, designing or selecting a custom panel involves more than...

Read More
Feb
Ultrasensitive Immunoassays Breakthrough: Detecting Low-Abundance Biomarkers

Ultrasensitive Immunoassays Breakthrough: Detecting Low-Abundance Biomarkers

For researchers in neuroscience, oncology, inflammation, and translational medicine, detecting biomarkers at vanishingly low concentrations can be a major challenge. These low-abundance biomarkers – often found at femtogram-per-milliliter levels – hold the key to early disease detection and nuanced understanding of disease biology. Traditional assays...

Read More
Jan
Multiplex cytokine analysis with PCA clustering and hierarchical dendrogram illustrating immune biomarker grouping and k-means clusters in immune profiling study

Multiplex Biomarker Profiling: Why Measuring Many Analytes Offers Deeper Biological Insight

Introduction: The Scientific Need for Multiplex Strategies Advances in biomarker technologies have transformed how researchers investigate immune responses, disease biology, and therapeutic mechanisms. Traditional single-analyte assays, such as ELISA, remain valuable tools for focused questions. However, complex biological systems rarely operate through a single pathway...

Read More
Nov
Unlocking Brain-Specific Alzheimer’s Biomarkers: The Power of BDpTau217 and BDpTau181 Assays for Research

Unlocking Brain-Specific Alzheimer’s Biomarkers: The Power of BDpTau217 and BDpTau181 Assays for Research

As the landscape of Alzheimer’s disease (AD) research continues to evolve, there is increasing demand for blood-based biomarkers that offer both precision and scalability. Among these, brain-derived phosphorylated tau (BDpTau) markers are gaining momentum for their unique ability to measure tau proteins sourced exclusively from...

Read More
Aug
Laboratory technician performing sample preparation with pipette for biomarker testing and multiplex assay analysis

Multiplex Cytokine Profiling in Cancer Immunotherapy: Uncovering Tumor Cytokine Biomarkers and Monitoring Cytokine Release Syndrome

Introduction Cancer immunotherapies harness the patient’s immune system, but individual responses vary widely. Measuring cytokines – small immune‐signaling proteins – can reveal how a patient’s immune system is reacting to therapy. Measuring cytokines such as interleukin‑6 (IL‑6) and interferon‑γ (IFN‑γ) reveals critical biomarkers involved in...

Read More
May
Multiplex assay comparison chart of Luminex, MSD, and ELISA highlighting sensitivity, dynamic range, sample volume requirements, throughput, and cost scalability for biomarker analysis

Multiplex Cytokine Assays Compared: Luminex®, Meso Scale Discovery®, and Traditional ELISA

Understanding the immune system often begins with one powerful tool: cytokine profiling. Whether you're studying inflammation, autoimmune disease, cancer immunotherapy, or vaccine responses, cytokine measurements offer a real-time view into immune activity. But with so many options available, selecting the right multiplex immune assay can...

Read More
Jan
Close-up image of the red and green lasers inside a Luminex machine, highlighting their role in bead-based assay detection.

The Power of Luminex® Technology for Cutting-Edge Clinical and Scientific Research

Introduction In the rapidly advancing world of biomedical research, efficient and precise data collection is crucial. As the demand for comprehensive insights into complex biological systems increases, researchers are turning to multiplex assays powered by Luminex platform. This breakthrough platform allows scientists to analyze multiple...

Read More